https://www.has-sante.fr/jcms/p_3498568/fr/lovenox-enoxaparine-sodique-traitement-antithrombotique 2024 false false false France evaluation of the transparency committee enoxaparin antithrombotic agents Treat During Treatment No Treatment for Diabetes Therapy Object fibrinolytic agents Treatment Epoch Treatment Biomaterial Treatment On Treatment Thrombolytic Agent GDC Treatment Frequency Terminology Treatment Study Enoxaparin Sodium lovenox